Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Change in Acquisitions & Divestments (2017 - 2019)

Cogent Biosciences has reported Change in Acquisitions & Divestments over the past 3 years, most recently at $8.0 million for Q2 2019.

  • Quarterly results put Change in Acquisitions & Divestments at $8.0 million for Q2 2019, up 19.34% from a year ago — trailing twelve months through Dec 2019 was $23.0 million (down 39.02% YoY), and the annual figure for FY2025 was $289.2 million, down 1.78%.
  • Change in Acquisitions & Divestments for Q2 2019 was $8.0 million at Cogent Biosciences, down from $15.0 million in the prior quarter.
  • Over the last five years, Change in Acquisitions & Divestments for COGT hit a ceiling of $15.0 million in Q4 2018 and a floor of $4.0 million in Q1 2017.
  • Median Change in Acquisitions & Divestments over the past 3 years was $6.4 million (2017), compared with a mean of $8.2 million.
  • Peak annual rise in Change in Acquisitions & Divestments hit 200.0% in 2018, while the deepest fall reached 11.67% in 2018.
  • Cogent Biosciences' Change in Acquisitions & Divestments stood at $5.0 million in 2017, then skyrocketed by 200.0% to $15.0 million in 2018, then tumbled by 46.69% to $8.0 million in 2019.
  • The last three reported values for Change in Acquisitions & Divestments were $8.0 million (Q2 2019), $15.0 million (Q1 2019), and $15.0 million (Q4 2018) per Business Quant data.